Lorence H. Kim - 31 Aug 2026 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Reporting relationship: Director
Issuer ticker: RVMD
Reported as of: 31 Aug 2026
Net transaction value: -$11,381,288
SEC form: 4
Accepted by SEC: 02 Sep 2026, 16:30:26 UTC
Prior SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jack Anders, as Attorney-in-fact for Lorence H. Kim

Key filing fact

Lorence H. Kim filed Form 4 for Revolution Medicines, Inc. (RVMD) on 02 Sep 2026.

Key facts

This page summarizes Lorence H. Kim's Form 4 filing for Revolution Medicines, Inc. (RVMD).
7 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 16:30.

Change

Previous filing in this sequence was filed on 23 Jun 2026.
Current net transaction value: -$11,381,288.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001643746 Primary reporting owner

Kim Lorence H.

Relationship: Director
Address: C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY
Signature: /s/ Jack Anders, as Attorney-in-fact for Lorence H. Kim
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Sale

Transaction value: $60,168
Shares: -300
Change %: -0.41%
Price: $200.56
Shares after: 72,790
Date: 31 Aug 2026
Ownership: Trust
Footnotes: F2, F3

RVMD transaction

Common Stock

Sale

Transaction value: $1,329,117
Shares: -6,597
Change %: -9.1%
Price: $201.47
Shares after: 66,193
Date: 31 Aug 2026
Ownership: Trust
Footnotes: F2, F3, F4

RVMD transaction

Common Stock

Sale

Transaction value: $2,615,864
Shares: -12,919
Change %: -20%
Price: $202.48
Shares after: 53,274
Date: 31 Aug 2026
Ownership: Trust
Footnotes: F2, F3, F5

RVMD transaction

Common Stock

Sale

Transaction value: $5,324,824
Shares: -26,160
Change %: -49%
Price: $203.55
Shares after: 27,114
Date: 31 Aug 2026
Ownership: Trust
Footnotes: F2, F3, F6

RVMD transaction

Common Stock

Sale

Transaction value: $1,485,830
Shares: -7,271
Change %: -27%
Price: $204.35
Shares after: 19,843
Date: 31 Aug 2026
Ownership: Trust
Footnotes: F2, F3, F7

RVMD transaction

Common Stock

Sale

Transaction value: $436,640
Shares: -2,128
Change %: -11%
Price: $205.19
Shares after: 17,715
Date: 31 Aug 2026
Ownership: Trust
Footnotes: F2, F3, F8

RVMD transaction

Common Stock

Sale

Transaction value: $128,846
Shares: -625
Change %: -3.5%
Price: $206.15
Shares after: 17,090
Date: 31 Aug 2026
Ownership: Trust
Footnotes: F2, F3, F9

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,191
Date: 31 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

Includes 1,191 restricted stock units.

Footnote F2

Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026.

Footnote F3

Shares held by the Lorence Kim Revocable Trust (the "Trust"). Of the 73,090 shares held by the Trust immediately prior to the transactions reported herein, 50,000 shares were acquired by the Trust in July 2022 and were previously reported as directly owned by the Reporting Person, and 23,090 shares were transferred by the Reporting Person to the Trust in August 2025. The August 2025 transfer effected only a change in the form of beneficial ownership without a change in the Reporting Person's pecuniary interest and was exempt pursuant to Rule 16a-13.

Footnote F4

The transaction was executed in multiple trades at prices ranging from $201.00 to $201.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F5

The transaction was executed in multiple trades at prices ranging from $202.00 to $202.9956, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F6

The transaction was executed in multiple trades at prices ranging from $203.0055 to $203.9968, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F7

The transaction was executed in multiple trades at prices ranging from $204.00 to $204.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F8

The transaction was executed in multiple trades at prices ranging from $205.00 to $205.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Footnote F9

The transaction was executed in multiple trades at prices ranging from $206.02 to $206.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.